IBDEI2YE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47136,2)
 ;;=^5008522
 ;;^UTILITY(U,$J,358.3,47137,0)
 ;;=I69.959^^181^2355^19
 ;;^UTILITY(U,$J,358.3,47137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47137,1,3,0)
 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,47137,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,47137,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,47138,0)
 ;;=D89.2^^181^2355^30
 ;;^UTILITY(U,$J,358.3,47138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47138,1,3,0)
 ;;=3^Hypergammaglobulinemia,Unspec
 ;;^UTILITY(U,$J,358.3,47138,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,47138,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,47139,0)
 ;;=B19.10^^181^2355^23
 ;;^UTILITY(U,$J,358.3,47139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47139,1,3,0)
 ;;=3^Hepatitis B w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,47139,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,47139,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,47140,0)
 ;;=B17.10^^181^2355^24
 ;;^UTILITY(U,$J,358.3,47140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47140,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
 ;;^UTILITY(U,$J,358.3,47140,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,47140,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,47141,0)
 ;;=B18.2^^181^2355^25
 ;;^UTILITY(U,$J,358.3,47141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47141,1,3,0)
 ;;=3^Hepatitis C,Chr/Carrier
 ;;^UTILITY(U,$J,358.3,47141,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,47141,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,47142,0)
 ;;=E03.9^^181^2355^39
 ;;^UTILITY(U,$J,358.3,47142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47142,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,47142,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,47142,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,47143,0)
 ;;=E16.2^^181^2355^36
 ;;^UTILITY(U,$J,358.3,47143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47143,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,47143,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,47143,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,47144,0)
 ;;=E78.1^^181^2355^31
 ;;^UTILITY(U,$J,358.3,47144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47144,1,3,0)
 ;;=3^Hyperglyceridemia,Pure
 ;;^UTILITY(U,$J,358.3,47144,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,47144,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,47145,0)
 ;;=E78.5^^181^2355^34
 ;;^UTILITY(U,$J,358.3,47145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47145,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,47145,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,47145,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,47146,0)
 ;;=E87.1^^181^2355^35
 ;;^UTILITY(U,$J,358.3,47146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47146,1,3,0)
 ;;=3^Hypo-osmolatlity & Hyponatremia
 ;;^UTILITY(U,$J,358.3,47146,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,47146,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,47147,0)
 ;;=E87.5^^181^2355^32
 ;;^UTILITY(U,$J,358.3,47147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47147,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,47147,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,47147,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,47148,0)
 ;;=E87.6^^181^2355^37
 ;;^UTILITY(U,$J,358.3,47148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47148,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,47148,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,47148,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,47149,0)
 ;;=G81.90^^181^2355^18
 ;;^UTILITY(U,$J,358.3,47149,1,0)
 ;;=^358.31IA^4^2
